(Reuters) – Britain’s AstraZeneca (AZN.L) said Thursday that good data is being obtained so far on its vaccine against COVID-19, which is already in large-scale human trials and is widely regarded as the leader in the race for a vaccine against the new coronavirus. . An employee is seen at …
Read More »
(Reuters) – Johnson & Johnson began human safety trials in the US on Thursday for its COVID-19 vaccine after publishing details of a study in monkeys that showed its best-performing candidate vaccine offered strong protection in a single dose. FILE PHOTO: The company logo for Johnson & Johnson is displayed …
Read More »
(Reuters) – Johnson & Johnson began human safety trials in the US on Thursday for its COVID-19 vaccine after publishing details of a study in monkeys that showed its best-performing candidate vaccine offered strong protection in a single dose. FILE PHOTO: The company logo for Johnson & Johnson is displayed …
Read More »
MOSCOW (Reuters) – Russia’s first potential COVID-19 vaccine will obtain local regulatory approval in the first half of August and be administered to front-line health workers soon after, a development source close to the matter told Reuters. FILE PHOTO: The Executive President of the Russian Direct Investment Fund, Kirill Dmitriev, …
Read More »
LONDON / PARIS (Reuters) – Britain has signed an agreement for up to 60 million doses of a possible COVID-19 vaccine developed by Sanofi (SASY.PA) and GlaxoSmithKline (GSK.L), he said Wednesday, heats up his fourth deal, like the race to tame the pandemic. FILE PHOTO: Small bottles labeled with “Vaccine” …
Read More »